Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$3K Sell
68
-839
-93% -$34.9K 0.15% 158
2016
Q4
$35K Sell
907
-470
-34% -$18.4K 0.17% 157
2016
Q3
$54K Sell
1,377
-142
-9% -$5.79K 0.27% 123
2016
Q2
$62K Buy
1,519
+51
+3% +$2.04K 0.3% 116
2016
Q1
$60K Sell
1,468
-1,719
-54% -$63.6K 0.26% 127
2015
Q4
$116K Sell
3,187
-2,771
-47% -$106K 0.5% 67
2015
Q3
$215K Buy
5,958
+1,637
+38% +$62.9K 0.96% 26
2015
Q2
$174K Sell
4,321
-2,665
-38% -$116K 0.72% 39
2015
Q1
$301K Sell
6,986
-193
-3% -$8.37K 1.2% 14
2014
Q4
$323K Buy
7,179
+3,495
+95% +$142K 1.27% 12
2014
Q3
$141K Sell
3,684
-3,508
-49% -$142K 0.58% 55
2014
Q2
$291K Hold
7,192
1.23% 15
2014
Q1
$294K Sell
7,192
-258
-3% -$9.82K 1.3% 14
2013
Q4
$285K Sell
7,450
-29
-0.4% -$997 1.3% 12
2013
Q3
$248K Sell
7,479
-874
-10% -$28.4K 1.24% 13
2013
Q2
$257K Buy
+8,353
New +$277K 1.18% 17

Other funds holding ORCL

New York Life Trust's ORCL Position: Q1 2017 in Review

New York Life Trust reduced its Oracle (ORCL) stake by 93% in Q1 2017, selling an estimated $34.9K and leaving 68 shares worth $3K. The position accounts for 0.15% of the portfolio, ranked #158.

New York Life Trust first reported a position in ORCL in Q2 2013 and has held it in 16 quarters since. The position peaked at $323K in Q4 2014. 1,574 funds tracked by Wall St. Rank hold ORCL as of Q1 2017.

  • New York Life Trust held 68 shares of Oracle worth $3K as of Q1 2017.
  • New York Life Trust sold 839 Oracle shares in Q1 2017, an estimated $34.9K.
  • Oracle made up 0.15% of New York Life Trust's portfolio in Q1 2017, its #158 holding.
  • New York Life Trust first reported a position in Oracle in Q2 2013 and has held it in 16 quarters since.
  • New York Life Trust's Oracle position peaked at $323K in Q4 2014.
  • 1,574 funds tracked by Wall St. Rank held Oracle as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.